Published in Eur J Obstet Gynecol Reprod Biol on March 25, 2008
Nucleotide variation in IL-10 and IL-12 and their receptors and cervical and vulvar cancer risk: a hybrid case-parent triad and case-control study. Int J Cancer (2013) 0.89
Single nucleotide polymorphisms in DNA repair genes and risk of cervical cancer: A case-control study. Oncol Lett (2011) 0.81
A multiscale systems perspective on cancer, immunotherapy, and Interleukin-12. Mol Cancer (2010) 0.79
Association of 42 SNPs with genetic risk for cervical cancer: an extensive meta-analysis. BMC Med Genet (2015) 0.77
Cervical Carcinogenesis and Immune Response Gene Polymorphisms: A Review. J Immunol Res (2017) 0.75
Association of interleukin-12 gene polymorphisms with cancer susceptibility: a meta-analysis. Int J Clin Exp Med (2015) 0.75
Vitamin D insufficiency in Korea--a greater threat to younger generation: the Korea National Health and Nutrition Examination Survey (KNHANES) 2008. J Clin Endocrinol Metab (2010) 2.41
NF-kappaB as a potential molecular target for cancer therapy. Biofactors (2007) 1.93
Adiponectin concentrations: a genome-wide association study. Am J Hum Genet (2010) 1.70
A nationwide seroepidemiology of hepatitis C virus infection in South Korea. Liver Int (2013) 1.57
Feasibility of ovarian preservation in patients with early stage endometrial carcinoma. Gynecol Oncol (2006) 1.57
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin. Gynecol Oncol (2012) 1.49
Analysis of the transforming growth factor beta1 gene -509 C/T polymorphism in patients with advanced-stage endometriosis. Fertil Steril (2009) 1.39
Preoperative identification of a low-risk group for lymph node metastasis in endometrial cancer: a Korean gynecologic oncology group study. J Clin Oncol (2012) 1.36
Current status of gynecological cancer in China. J Gynecol Oncol (2009) 1.32
Characteristics of body fat, body fat percentage and other body composition for Koreans from KNHANES IV. J Korean Med Sci (2011) 1.31
Prognostic value of preoperative metabolic tumor volume and total lesion glycolysis in patients with epithelial ovarian cancer. Ann Surg Oncol (2011) 1.28
TP53 codon 72 polymorphism and cervical cancer: a pooled analysis of individual data from 49 studies. Lancet Oncol (2009) 1.26
Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod (2008) 1.26
Curcumin inhibits phorbol ester-induced expression of cyclooxygenase-2 in mouse skin through suppression of extracellular signal-regulated kinase activity and NF-kappaB activation. Carcinogenesis (2003) 1.25
Akt involvement in paclitaxel chemoresistance of human ovarian cancer cells. Ann N Y Acad Sci (2007) 1.23
Polymorphism in folate- and methionine-metabolizing enzyme and aberrant CpG island hypermethylation in uterine cervical cancer. Gynecol Oncol (2005) 1.18
Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer. Acta Obstet Gynecol Scand (2006) 1.16
Improvements to the FIGO staging for ovarian cancer: reconsideration of lymphatic spread and intraoperative tumor rupture. J Gynecol Oncol (2013) 1.15
Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol (2006) 1.13
Trends in cervical cancer mortality in Korea 1993-2002: corrected mortality using national death certification data and national cancer incidence data. Int J Cancer (2008) 1.11
Seoul National University Bundang Hospital's Electronic System for Total Care. Healthc Inform Res (2012) 1.10
Role of [18F]FDG PET/CT in the assessment of suspected recurrent ovarian cancer: correlation with clinical or histological findings. Eur J Nucl Med Mol Imaging (2006) 1.09
Follicle-stimulating hormone receptor gene polymorphism and ovarian responses to controlled ovarian hyperstimulation for IVF-ET. J Hum Genet (2006) 1.08
Gamma-knife radiosurgery as an optimal treatment modality for brain metastases from epithelial ovarian cancer. Gynecol Oncol (2008) 1.07
Hysteroscopic resection of the vaginal septum in uterus didelphys with obstructed hemivagina: a case report. J Korean Med Sci (2007) 1.07
Prognostic value of metabolic tumor volume measured by FDG-PET/CT in patients with cervical cancer. Gynecol Oncol (2010) 1.06
A hospital-based case-control study of identifying ovarian cancer using symptom index. J Gynecol Oncol (2009) 1.06
Expression of vascular endothelial growth factor and hypoxia inducible factor-1alpha in cervical neoplasia. Ann N Y Acad Sci (2009) 1.05
Activation of mTOR signaling pathway associated with adverse prognostic factors of epithelial ovarian cancer. Gynecol Oncol (2011) 1.04
[Distribution of hepatitis B virus genotypes in Korea]. Korean J Hepatol (2009) 1.04
Genetic polymorphisms affecting clinical outcomes in epithelial ovarian cancer patients treated with taxanes and platinum compounds: a Korean population-based study. Gynecol Oncol (2009) 1.04
The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study. Ann Surg Oncol (2009) 1.02
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition. J Gynecol Oncol (2013) 1.02
XRCC1 R399Q polymorphism is associated with response to platinum-based neoadjuvant chemotherapy in bulky cervical cancer. Gynecol Oncol (2006) 1.02
Multiple HPV infection in cervical cancer screened by HPVDNAChip. Cancer Lett (2003) 1.02
Association between excision repair cross-complementation group 1 polymorphism and clinical outcome of platinum-based chemotherapy in patients with epithelial ovarian cancer. Exp Mol Med (2006) 1.01
Association between shift work and obesity among female nurses: Korean Nurses' Survey. BMC Public Health (2013) 1.01
Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol (2010) 1.00
Rapid and high-throughput analysis of N-glycans from ovarian cancer serum using a 96-well plate platform. Anal Biochem (2009) 1.00
The clinical impact of [(18)F]FDG PET/CT for the management of recurrent endometrial cancer: correlation with clinical and histological findings. Eur J Nucl Med Mol Imaging (2008) 0.99
FAS -1377 G/A polymorphism and the risk of lymph node metastasis in cervical cancer. Cancer Genet Cytogenet (2008) 0.99
Carriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean males. PLoS One (2011) 0.99
How low is low enough? Evaluation of various risk-assessment models for lymph node metastasis in endometrial cancer: a Korean multicenter study. J Gynecol Oncol (2012) 0.98
Epidemiological characteristics of ovarian cancer in Korea. J Gynecol Oncol (2010) 0.98
Involvement of NF-kappaB and AP-1 in COX-2 upregulation by human papillomavirus 16 E5 oncoprotein. Carcinogenesis (2009) 0.98
Concurrent radiotherapy with paclitaxel/carboplatin chemotherapy as a definitive treatment for squamous cell carcinoma of the uterine cervix. Gynecol Oncol (2006) 0.97
Rare metastases of recurrent cervical cancer to the pericardium and abdominal muscle. Arch Gynecol Obstet (2008) 0.97
Major clinical research advances in gynecologic cancer in 2011. J Gynecol Oncol (2012) 0.97
Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer. Onkologie (2008) 0.97
Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target. J Cancer Res Clin Oncol (2004) 0.97
Polymorphism in the nuclear factor kappa-B binding promoter region of cyclooxygenase-2 is associated with an increased risk of bladder cancer. Cancer Lett (2005) 0.97
Identification of genes with differential expression in chemoresistant epithelial ovarian cancer using high-density oligonucleotide microarrays. Oncol Res (2009) 0.97